Navigantis is creating a surgical robotic for a variety of neurovascular indications, together with acute ischemic stroke. | Supply: Navigantis
Navigantis Inc. final week introduced the primary profitable medical procedures carried out with its Vasco surgical robotic for sufferers affected by neurovascular problems. The interventional instances concerned sufferers present process diagnostic cerebral angiogram, mind tumor embolization, and mechanical thrombectomy for ischemic stroke.
“This achievement marks an necessary milestone in our mission to introduce the benefits of robotic procedures to the interventional neurovascular subject,” acknowledged Mor Dayan, CEO of Navigantis.
“The Vasco robotic platform has the potential to redefine how we strategy probably the most complicated and time-sensitive neurovascular procedures, finally enhancing each affected person outcomes and procedural efficiencies,” he added. “This is likely one of the first steps in the direction of enabling robotic telesurgery for stroke sufferers, which might dramatically cut back response occasions and improve entry to well timed vital care.”
Neurovascular ailments require well timed therapy
Neurovascular ailments, together with stroke, aneurysms, and arteriovenous malformations (AVMs) are main causes of demise and incapacity worldwide, in line with Navigantis. Strokes have an effect on somebody within the U.S. each 40 seconds, and they’re the main reason for incapacity.
Mechanical thrombectomy (MT) is now the “gold normal” for acute ischemic stroke, famous the Miami-based firm. If a affected person receives MT inside two hours from the onset of signs, she or he has a 90% probability of re-achieving independence. At six hours, the quantity drops to 30%.
Navigantis asserted that these numbers reaffirm the significance of making certain that procedures are well timed and broadly out there. They’re presently constrained by the inadequate variety of educated neuro-interventionalists and the restricted entry outdoors city areas.
Regardless of enhancements in stroke programs of care, many People nonetheless lack well timed entry to acute stroke intervention, Navigantis mentioned.
Register at this time to avoid wasting 40% on convention passes!
Navigantis takes steps to extra complicated surgical procedure
Based in 2022, Navigantis has developed an interventional robotic platform for a variety of neurovascular procedures and indications, together with acute ischemic stroke. VASCO is an investigational system and is presently present process medical analysis outdoors the U.S. It’s not authorized for industrial use in any jurisdiction, together with the U.S.
As extra endovascular procedures requiring fluoroscopy for imaging steerage are carried out to deal with neurovascular ailments, it has change into vitally necessary to give attention to reducing radiation publicity. The appliance of robotics for interventional procedures will tremendously cut back it, Navigantis mentioned.
Prof. Dong Joon Kim, a pioneer within the robotic neuro-interventional area and the chairman of radiology at Severance Hospital in Seoul, South Korea, led the examine.
“These first profitable robotic instances are a significant stepping stone in the direction of treating extra complicated neurovascular ailments,” mentioned Prof. Kim.
The corporate mentioned this achievement builds on its earlier first-in-human (FIH) trials in 2022, during which physicians used the earlier technology of VASCO to efficiently carry out robotic embolization of liver tumors.
In July 2024, Navigantis closed a $12 million Sequence A funding spherical. The corporate mentioned proceeds from the financing will likely be used to help the continuing growth and testing of the robotic to convey VASCO to FIH medical trials for neurovascular procedures.
The Navigantis workforce on the Society of Robotic Surgical procedure. From left to proper: Hyosig Kang, the co-founder and CTO; Mor Dayan, co-founder and CEO; and Marc Camprubí Artal, head of operations. | Supply: Navigantis through LinkedIn